Overview

Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD

Status:
Unknown status

Trial end date:
2020-07-01

Target enrollment:

Participant gender:

Summary

The objective of the present study was to evaluate the prognostic impact of prolonged dual antiplatelet therapy (DAPT) with acetylsalicylic acid plus clopidogrel on the incidence of major adverse cardiovascular events and major adverse limb events after percutaneous lower extremity revascularization in patients with lower extremity peripheral arterial disease (LE-PAD).

Phase:

Phase 3

Details

Lead Sponsor:

Federico II University

Treatments:

Aspirin
Clopidogrel
Ticlopidine